BURLINGTON, North Carolina -- LabCorp has received emergency use authorization from the Food and Drug Administration for its Pixel at home coronavirus test kit. The COVID-19 At Home Test Kit allows ...

LabCorp on Tuesday announced the launch of the first testing method to simultaneously detect for COVID-19, influenza A / B, and respiratory syncytial virus (RSV) ahead of flu season. CDC tells states: ...

As syphilis cases surge nationwide, the collaboration will bring the First To Know ® over-the-counter test to clinicians and patients across professional and hospital settings SPRINGDALE, ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...

Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C., Oct 10, 2024 /PRNewswire/ -- ...

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests. Labcorp is paying $192.5 million for ...

Labcorp has completed its previously announced acquisition of select assets of BioReference Health, a wholly owned subsidiary ...